These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 36939389)
21. Growth effects of botulinum toxin type A injected unilaterally into the masseter muscle of developing rats. Park C; Park K; Kim J J Zhejiang Univ Sci B; 2015 Jan; 16(1):46-51. PubMed ID: 25559955 [TBL] [Abstract][Full Text] [Related]
22. The Effect of Intragastric Administration of Botulinum Toxin Type A on Reducing Adiposity in a Rat Model of Obesity Using Micro-CT and Histological Examinations. Park JS; Zheng HM; Kim JM; Kim CS; Jeong S; Lee DH Gut Liver; 2017 Nov; 11(6):798-806. PubMed ID: 28750487 [TBL] [Abstract][Full Text] [Related]
23. [Small doses of gentamicin drum indoor injection treatment of intractableMénière disease clinical observation of the impact of the hearing]. Wang XY Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(12):942-944. PubMed ID: 29771059 [No Abstract] [Full Text] [Related]
24. The influence of botulinum toxin on auditory disturbances in hemifacial spasm. Rudzińska M; Wójcik M; Zajdel K; Hydzik-Sobocińska K; Malec M; Hartel M; Składzień J; Szczudlik A Neurol Neurochir Pol; 2012; 46(1):29-36. PubMed ID: 22426760 [TBL] [Abstract][Full Text] [Related]
26. [Botulinum toxin to treat sweat caused sequelae in patients with hearing aids, active middle ear implants and cochlear implants]. Laskawi R; Winterhoff J; Blum J; Matthias C HNO; 2012 Nov; 60(11):1007-10. PubMed ID: 22733280 [TBL] [Abstract][Full Text] [Related]
27. Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial. Park H; Shin S; Shin HS; Kim HW; Kim DW; Lee DH Clin Orthop Relat Res; 2016 Dec; 474(12):2705-2711. PubMed ID: 27506971 [TBL] [Abstract][Full Text] [Related]
28. Round Window Niche Drilling with Intratympanic Steroid Is a Salvage Therapy of Sudden Hearing Loss. Si Y; Jiang HL; Chen YB; Chu YG; Chen SJ; Chen XM; He WH; Zheng YQ; Zhang ZG Audiol Neurootol; 2018; 23(6):309-315. PubMed ID: 30630184 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the protective effect of Botulinum toxin type A injection on otitis media with effusion Çalım ÖF; Yıldırım YS; Doğan R; Tuğrul S; Gedik Ö; Özturan O Acta Otolaryngol; 2017 Sep; 137(9):917-922. PubMed ID: 28434389 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin in masticatory muscles of the adult rat induces bone loss at the condyle and alveolar regions of the mandible associated with a bone proliferation at a muscle enthesis. Kün-Darbois JD; Libouban H; Chappard D Bone; 2015 Aug; 77():75-82. PubMed ID: 25857689 [TBL] [Abstract][Full Text] [Related]
32. Management of palatal myoclonic tinnitus based on clinical characteristics: a large case series study. Park JM; Kim WJ; Han JS; Park SY; Park SN Acta Otolaryngol; 2020 Jul; 140(7):553-557. PubMed ID: 32406274 [No Abstract] [Full Text] [Related]
33. Design and implementation of botulinum toxin on cricopharyngeal dysfunction guided by a combination of catheter balloon, ultrasound, and electromyography (BECURE) in patients with stroke: study protocol for a randomized, double-blinded, placebo-controlled trial. Xie M; Dou Z; Wan G; Zeng P; Wen H Trials; 2021 Mar; 22(1):238. PubMed ID: 33789722 [TBL] [Abstract][Full Text] [Related]
34. The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study. Rezazadeh F; Esnaashari N; Azad A; Emad S BMC Oral Health; 2022 May; 22(1):217. PubMed ID: 35641993 [TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA; Fallico N; Mazzocchi M; Scuderi N Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing. Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632 [TBL] [Abstract][Full Text] [Related]
37. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199 [TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A. Alster TS; Lupton JR Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Chen Y; Tsai CH; Bae TH; Huang CY; Chen C; Kang YN; Chiu WK Aesthetic Plast Surg; 2023 Apr; 47(2):775-790. PubMed ID: 36694050 [TBL] [Abstract][Full Text] [Related]
40. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection. Quaranta A; Aloisi A; De Benedittis G; Scaringi A Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]